AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Tamsulosin HCl 0.4 Mg ;

11 registrations across 1 African market— 11 active

Markets with Tamsulosin HCl 0.4 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Tamsul
Hard Gelatin Capsules Containing Extended Release Pellets
🇪🇬EgyptAmoun Pharmaceutical Companyactive
Tamsulin ®
MODIFIED RELEASE HARD GELATIN CAPSULE
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Urizetinax
MODIFIED RELEASE HARD GELATIN CAPSULE
🇪🇬EgyptZeta Pharma for Pharmaceutical Industries (Zeta Pharma)active
Flowtex
Modified Release capsules containing pellets
🇪🇬EgyptInternational advanced pharmaceutical industries (INAD pharma)active
Tamsumerican
Hard gelatin capsules containing pellets
🇪🇬EgyptPAXAL PHARMACEUTICALactive
Flowtex
Modified Release capsules containing pellets
🇪🇬EgyptInternational advanced pharmaceutical industries (INAD pharma)active
Tamsul
Hard Gelatin Capsules Containing Extended Release Pellets
🇪🇬EgyptAmoun Pharmaceutical Companyactive
Tamsulin ®
MODIFIED RELEASE HARD GELATIN CAPSULE
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Tamsumerican
Hard gelatin capsules containing pellets
🇪🇬EgyptPAXAL PHARMACEUTICALactive
Omnic Ocas™ 0.4
Prolonged Release Film coated Tablet
🇪🇬EgyptAstellas Pharma International B.V.active
Urizetinax
MODIFIED RELEASE HARD GELATIN CAPSULE
🇪🇬EgyptZeta Pharma for Pharmaceutical Industries (Zeta Pharma)active

Tamsulosin HCl 0.4 Mg ; in Africa — Regulatory Overview

Tamsulosin HCl 0.4 Mg ; is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.